Search Results - "Kapatais, Andreas"
-
1
HERACLIS‐TAF: a multi‐centre prospective cohort study on 2‐year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risks
Published in Alimentary pharmacology & therapeutics (01-08-2022)“…Summary Background Tenofovir alafenamide (TAF) has exhibited a favourable safety profile on estimated glomerular filtration (eGFR) and bone mineral density…”
Get full text
Journal Article -
2
-
3
Prevalence and predictors of HDV viremia in anti-HDV positive patients of the HEllenic multicenter ReAl-life CLInical Study (HERACLIS-HDV)
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
4
Two-year safety and efficacy of tenofovir alafenamide in chronic hepatitis B: a HEllenic multicenter ReAl-life CLInical Study (HERACLIS-TAF)
Published in Journal of hepatology (01-07-2022)Get full text
Journal Article -
5
Incidence of primary hepatitis C infection among people who inject drugs during 2012–2020 in Athens, Greece
Published in Journal of viral hepatitis (01-08-2024)“…One of the World Health Organization's targets for the 2030 viral hepatitis elimination strategy is to reduce new hepatitis C (HCV) infections. In Athens,…”
Get full text
Journal Article -
6
High levels of all-cause mortality among people who inject drugs from 2018 to 2022
Published in The International journal of drug policy (01-04-2024)“…Mortality among people who inject drugs (PWID) is high, with overdose and HIV infection being the main causes of death. In Greece, there have been no data on…”
Get full text
Journal Article -
7
HERACLIS‐HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg‐positive patients
Published in Liver international (01-09-2023)“…Background and Aims Hepatitis D virus (HDV) underdiagnosis remains common. We assessed the HDV screening and prevalence rates in HBsAg‐positive patients seen…”
Get full text
Journal Article -
8
Real-world experience from tenofovir alafenamide use in chronic hepatitis B: an Hellenic multicenter real-life clinical study (HERACLIS-TAF)
Published in Journal of hepatology (01-08-2020)Get full text
Journal Article -
9
-
10
-
11
-
12
Sa1512 - Predictors of Sustained Virological Response (SVR) in Patients with Advanced Chronic Hepatitis C (CHC) Treated with Current Direct Acting Antiviral(s) (DAA). Heraclis: Hellenic Multicenter Real-Life Cohort Study
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2017)Get full text
Journal Article -
13
Predictors of Sustained Virological Response (SVR) in Patients with Advanced Chronic Hepatitis C (CHC) Treated with Current Direct Acting Antiviral(s) (DAA). Heraclis: Hellenic Multicenter Real-Life Cohort Study
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2017)Get full text
Journal Article